This contract expires in 429 days (Dec 31, 2027).
LEIDOS BIOMEDICAL RESEARCH INC - CORE SUPPORT FOR THE IMMUNE CELL NETWORK
Key Details
Description
CORE SUPPORT FOR THE IMMUNE CELL NETWORK
Context & Analysis
On Sep 15, 2021, Department of Health and Human Services obligated $26,946,544 to LEIDOS BIOMEDICAL RESEARCH INC for core support for the immune cell network. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Dec 31, 2027 — approximately 14 months remaining.
Market context
- Recompete outlook
- Ends Dec 31, 2027, in 14 months. Recompete signal as of Oct 19, 2026: 49/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 85% of 500 awards in this market (Department of Health and Human Services awards in NAICS 541715 over the last 3 years) were competed; median 2 offers.
- Award size
- At $26.9M, this award is larger than three in four of the 530 priced Department of Health and Human Services awards in NAICS 541715 over the last 3 years (median $1.7M).
- Incumbent at this agency
- LEIDOS BIOMEDICAL RESEARCH INC has 69 other awards from Department of Health and Human Services, totalling $2.9B, 2016–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541715 over the last 3 years.
- LEIDOS HOLDINGS, INC. — 59 awards, $2.3B
- THE MITRE CORPORATION — 40 awards, $315.7M
- WESTAT, INC. — 11 awards, $222.2M
- BATTELLE MEMORIAL INSTITUTE — 3 awards, $121.5M
- DUKE UNIVERSITY — 16 awards, $117.6M
Computed from USAspending award data on Oct 19, 2026.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.